IPP Bureau

Indian pharma growth likely to moderate in FY23: ICRA
Indian pharma growth likely to moderate in FY23: ICRA

By IPP Bureau - April 07, 2022

Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23

All India Institute of Ayurveda signs MoU with Safdarjung hospital
All India Institute of Ayurveda signs MoU with Safdarjung hospital

By IPP Bureau - April 07, 2022

The MoU sets down the guidelines for the establishment of an integrative medicine unit, joint research and academic activities in various fields of interest in Ayurveda and modern medicine

Alembic gets USFDA tentative approval for dabigatran etexilate capsules
Alembic gets USFDA tentative approval for dabigatran etexilate capsules

By IPP Bureau - April 07, 2022

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim

Lupin launches Merzee capsules in the United States
Lupin launches Merzee capsules in the United States

By IPP Bureau - April 07, 2022

Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International

CDMOs shifting focus to meet future demand
CDMOs shifting focus to meet future demand

By IPP Bureau - April 07, 2022

An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines

New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays
New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays

By IPP Bureau - April 07, 2022

The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format

Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19

By IPP Bureau - April 06, 2022

Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19

Pristyn Care’s new app enables location-based discovery of doctors
Pristyn Care’s new app enables location-based discovery of doctors

By IPP Bureau - April 06, 2022

An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation

Hataali wins US patent for the use of blockchain in advanced medicinal therapy
Hataali wins US patent for the use of blockchain in advanced medicinal therapy

By IPP Bureau - April 06, 2022

The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award

MilliporeSigma acquires MAST platform from Lonza
MilliporeSigma acquires MAST platform from Lonza

By IPP Bureau - April 06, 2022

MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies

BioFluidica to introduce next-generation biomarker isolation platform
BioFluidica to introduce next-generation biomarker isolation platform

By IPP Bureau - April 06, 2022

BioFluidica LiquidScan harnesses the power of microfluidics

Singlera Genomics announces research collaboration with Astellas Pharma
Singlera Genomics announces research collaboration with Astellas Pharma

By IPP Bureau - April 06, 2022

The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals

GE Healthcare and Elekta sign global collaboration agreement
GE Healthcare and Elekta sign global collaboration agreement

By IPP Bureau - April 06, 2022

GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets

Iktos and Teijin Pharma to co-develop technology for small molecule drug discovery
Iktos and Teijin Pharma to co-develop technology for small molecule drug discovery

By IPP Bureau - April 06, 2022

Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process

ENTOD Pharma bullish on Macushield sales
ENTOD Pharma bullish on Macushield sales

By IPP Bureau - April 06, 2022

Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision

Latest Stories

Interviews

Packaging